A	O
novel	O
Cd8	O
-	O
cis	O
-	O
regulatory	O
element	O
preferentially	O
directs	O
expression	O
in	O
CD44hiCD62L	O
+	O
CD8	O
+	O
T	O
cells	O
and	O
in	O
CD8alphaalpha	O
+	O
dendritic	O
cells	O
.	O


CD8	O
coreceptor	O
expression	O
is	O
dynamically	O
regulated	O
during	O
thymocyte	O
development	O
and	O
is	O
tightly	O
controlled	O
by	O
the	O
activity	O
of	O
at	O
least	O
5	O
different	O
cis	O
-	O
regulatory	O
elements	O
.	O


Despite	O
the	O
detailed	O
characterization	O
of	O
the	O
Cd8	O
loci	O
,	O
the	O
regulation	O
of	O
the	O
complex	O
expression	O
pattern	O
of	O
CD8	O
cannot	O
be	O
fully	O
explained	O
by	O
the	O
activity	O
of	O
the	O
known	O
Cd8	O
enhancers	O
.	O


In	O
this	O
study	O
,	O
we	O
revisited	O
the	O
Cd8ab	O
gene	O
complex	O
with	O
bioinformatics	O
and	O
transgenic	O
reporter	O
gene	O
expression	O
approaches	O
to	O
search	O
for	O
additional	O
Cd8	O
cis	O
-	O
regulatory	O
elements	O
.	O


This	O
led	O
to	O
the	O
identification	O
of	O
an	O
ECR	O
(	O
ECR	O
-	O
4	O
)	O
,	O
which	O
in	O
transgenic	O
reporter	O
gene	O
expression	O
assays	O
,	O
directed	O
expression	O
preferentially	O
in	O
CD44	O
(	O
hi	O
)	O
CD62L	O
(	O
+	O
)	O
CD8	O
(	O
+	O
)	O
T	O
cells	O
,	O
including	O
innate	O
-	O
like	O
CD8	O
(	O
+	O
)	O
T	O
cells	O
.	O


ECR	O
-	O
4	O
,	O
designated	O
as	O
Cd8	O
enhancer	O
E8VI	O
,	O
was	O
bound	O
by	O
Runx	O
/	O
CBFbeta	O
complexes	O
and	O
Bcl11b	O
,	O
indicating	O
that	O
E8VI	O
is	O
part	O
of	O
the	O
cis	O
-	O
regulatory	O
network	O
that	O
recruits	O
transcription	O
factors	O
to	O
the	O
Cd8ab	O
gene	O
complex	O
in	O
CD8	O
(	O
+	O
)	O
T	O
cells	O
.	O


Transgenic	O
reporter	O
expression	O
was	O
maintained	O
in	O
LCMV	O
-	O
specific	O
CD8	O
(	O
+	O
)	O
T	O
cells	O
upon	O
infection	O
,	O
although	O
short	O
-	O
term	O
,	O
in	O
vitro	O
activation	O
led	O
to	O
a	O
down	O
-	O
regulation	O
of	O
E8VI	O
activity	O
.	O


Finally	O
,	O
E8VI	O
directed	O
transgene	O
expression	O
also	O
in	O
CD8alphaalpha	O
(	O
+	O
)	O
DCs	O
but	O
not	O
in	O
CD8alphaalpha	O
-	O
expressing	O
IELs	O
.	O


Taken	O
together	O
,	O
we	O
have	O
identified	O
a	O
novel	O
Cd8	O
enhancer	O
that	O
directs	O
expression	O
in	O
CD44	O
(	O
hi	O
)	O
CD62L	O
(	O
+	O
)	O
CD8	O
(	O
+	O
)	O
T	O
cells	O
,	O
including	O
innate	O
-	O
like	O
and	O
antigen	O
-	O
specific	O
effector	O
/	O
memory	O
CD8	O
(	O
+	O
)	O
T	O
cells	O
and	O
in	O
CD8alphaalpha	O
(	O
+	O
)	O
DCs	O
,	O
and	O
thus	O
,	O
our	O
data	O
provide	O
further	O
insight	O
into	O
the	O
cis	O
-	O
regulatory	O
networks	O
that	O
control	O
CD8	O
expression	O
.	O
